Uniting leading analytical, formulation, process development and CMC experts from Pfizer, AstraZeneca, Tessera Therapeutics, Beam Therapeutics, Moderna, Editas Medicines and more, the 5th LNP Formulation & Process Development Summit (April 6-8, 2026, Boston, MA) is returning to advance specific, stable and scalable LNPs from concept to market.
The flagship LNP Summit will bring together 180+ global LNP trailblazers, where you can gain exclusive access to LNP-specific networking, partnership opportunities and collaborative discussions to drive the next generation of LNPs towards the clinic.
With 3 focused streams, Analytical Development & Characterization, Formulation & Delivery and Process Development & Manufacturing, this is your opportunity to overcome challenges in achieving precise extrahepatic delivery, robust characterization of targeted LNPs and optimal formulations for ambient storage, all towards making LNP drug products more selective, safe and potent. To support team-wide learning, groups receive up to 20% discount.
If you’re interested in learning more: Click here
Or, to register your ticket with discounted rates: Click here